Estudio de seguridad, fase I de ensayo clínico, de la gammaglobulina hiperinmune anti-hepatitis B administrada unisitio y junto con la vacuna AgsHB recombinante: resultados preliminares

Acosta Acosta, Josué; González Griego, Antonio; Caro Machado, Ramón; González Martínez, Victoria E; García Castillo, Elsa; Santiesteban Torres, Jorge A; Arlem González, Alina; Montenegro, Adonis.
Rev. cuba. invest. bioméd ; 23(1)ene.-mar. 2004. tab
Artículo en Español | CUMED | ID: cum-23430

Documentos relacionados

  1. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
  2. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
  3. [Hepatitis B, prevalence and results of preventive measures in dialysis centers].
  4. Hepatitis B vaccination.
  5. [Combined passive and active immunization of infants of HbsAg-positive mothers].
  6. [Anti-hepatitis B vaccine].
  7. Hepatitis B: perceptions, knowledge and vaccine acceptance among registered nurses in high-risk occupations in a university hospital.
  8. [Towards a bivalent prophylactic vaccine against hepatitis B and C viruses?].
  9. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
  10. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections.